Natco Pharma Ltd.
NATCOPHARM · ISIN: INE987B01026
Constituent of NIFTY 500 TRI (0.04%), NIFTY MC 150 TRI (0.29%), NIFTY SC 250 TRI (0.38%)
Earnings (TTM)
CHART
Natco Pharma Ltd. - revenue & profit (TTM)
Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.
33.03%
EBITDA Margin (TTM)
63.89
EPS (TTM)
35.21%
EPS Growth (5Y)
10.43%
EPS Growth (10Y)
Technicals
31.11
RSI (14)
911.61
SMA (50)
945.69
SMA (200)
16.27
ADX (14)
1226.8
52-Week High
789
52-Week Low
-4.61%
1Y Return
45.4122
Avg Traded Value (20D, ₹Cr)
As of 2026-09-08.
Shareholding Pattern
CHART
Shareholding by category
As of 2026-06-30.
Corporate Actions
No corporate actions on record for this stock.
Recent Deals
No recent block/bulk/short-sell deals on record for this stock.
Stock data · Not financial advice · Past performance does not indicate future returns